NEW YORK (360Dx) – Roche today said that the US Food and Drug Administration has approved the firm's fourth-generation HIV combination antigen-antibody assay for marketing.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.